Antibody library display on a mammalian virus vector: Combining the advantages of both phage and yeast display into one technology

Current Drug Discovery Technologies

Volumn 11, Issue 1, 2014, Pages 48-55

  Smith, Ernest S ^a   Zauderer, Maurice ^a  

^a VACCINEX INC   (United States)

Author keywords

Expression library; Human antibody selection; Vaccinia virus

Indexed keywords

ANTIBODY; CH1 A56R FUSION PROTEIN; HYBRID PROTEIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS VECTOR;

ANTIBODY LIBRARY; ANTIBODY SPECIFICITY; ARTICLE; CELL SELECTION; HELA CELL LINE; HUMAN; MAMMAL CELL; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; VACCINIA VIRUS; VIRION; YEAST;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL SURFACE DISPLAY TECHNIQUES; HUMANS; POXVIRIDAE; RECOMBINANT FUSION PROTEINS;

EID: 84900871571     PISSN: 15701638     EISSN: 18756220     Source Type: Journal    
DOI: 10.2174/157016381101140124163634     Document Type: Article

References (17)

1. Hoogenboom HR. Selecting and screening recombinant antibody libraries. Nat Biotechnol 2005; 23(9): 1105-16.
2. Ponsel D, Neugebauer J, Ladetzki-Baehs K, Tissot K. High Affinity, Developability and Functional Size: The Holy Grail of Combinatorial Antibody Library Generation. Molecules 2011 ; 16(5): 3675-700.
3. Moss B. Vaccinia virus: A tool for research and vaccine development. Science 1991; 252(5013): 1662-7.
4. Smith ES, Mandokhot A, Evans EE, et al. Lethality-based selection of recombinant genes in mammalian cells: Application to identifying tumor antigens. Nat Med 2001; 7(8): 967-72.
5. Smith ES, Shi S, Zauderer M. Construction of cDNA libraries in vaccinia virus. Methods Mol Biol 2004; 269: 65-76.
6. Smith ES, and Zauderer M. Antibody Selection from Immunoglobulin Libraries Expressed in Mammalian Cells. In Therapeutic Antibodies: From Bench to Clinic. Edited by Zhiqiang An 2009 by John Wiley and Sons, inc. p283-307.
7. Merchant AM, Zhu Z, Yuan JQ, et al. An efficient route to human bispecific IgG. Nat Biotechnol 1998; 16(7): 677-81.
8. Nissim A, Hoogenboom HR, Tomlinson IM, et al. Antibody fragments from a 'single pot' phage display library as immunochemical reagents. EMBO J 1994; 13(3): 692-8.
9. Shi L, Wheeler JC, Sweet RC, et al. De Novo Selection of High-Affinity Antibodies fromSynthetic Fab Libraries Displayed on Phage as pIX Fusion Proteins. J Mol Biol 2010; 397: 385-96.
10. Roberts KL, Smith GL. Vaccinia virus morphogenesis and dissemination. Trends Microbiol 2008; 16: 472-9.
11. Husain M, Weisberg AS, Moss B. Existence of an operative pathway from the endoplasmic reticulum to the immature poxvirus membrane. Proc Natl Acad Sci USA 2006; 19; 103(51): 19506-11.
12. Husain M, Weisberg AS, Moss B. Sequence-Independent Targeting of Transmembrane Proteins Synthesized within Vaccinia Virus Factories to Nascent Viral Membranes. J Virol 2007; 81(6): 2646-55.
13. Smith GL, Vanderplasschen A, Law M. The formation and function of extracellular enveloped vaccinia virus. J Gen Virol 2002; 83(Pt 12): 2915-31.
14. Dehaven BC, Gupta K, Isaacs SN. The vaccinia virus A56 protein: A multifunctional transmembrane glycoprotein that anchors two secreted viral proteins. J Gen Virol 2011; 92(Pt 9): 1971-80.
15. Galmiche MC, Rindisbacher L, Wels W, Wittek R, Buchegger F. Expression of a functional single chain antibody on the surface of extracellular enveloped vaccinia virus as a step towards selective tumour cell targeting. J Gen Virol 1997; 78(Pt 11): 3019-27.
16. Evans EE, Henn AD, Jonason A, et al. C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer. Mol Cancer Ther 2006; 5(11): 2919-30.
17. Hall KT, Boumsell L, Schultze JL, et al. Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc Natl Acad Sci USA 1996; 93(21): 11780-5.